Your session is about to expire
← Back to Search
Surgery-Related Lymphedema for Uterine and Gynecologic Cancers (LEG Trial)
LEG Trial Summary
This trial looks at lymphedema after surgery in patients with endometrial, cervical, or vulvar cancer.
LEG Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowLEG Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.LEG Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I had a sentinel node biopsy without plans for complete lymph node removal.to the study chair and other study personnel
In order to participate in the study, patients must sign an informed consent form that allows their personal health information to be released to the study chair and other study personnel.into the study
Patients must have a serum albumin level of >= 3.0 within 14 days of starting the study.I had or will have surgery for early-stage cervical cancer.My surgery is scheduled within 5 days before or 8 weeks after joining the study.I have or will have surgery for uterine, cervical, or vulvar cancer.My surgery is scheduled within 5 days before or 8 weeks after joining the study.I have a history of chronic swelling in my legs.I had cancer before and was treated with surgery.I have had radiation therapy in the pelvic, abdominal, inguinal, or leg area.I had or will have surgery for early-stage uterine cancer, including removal of the uterus and ovaries.I had or will have surgery for vulvar cancer, including lymph node removal.I am having or had another surgery besides lymph node removal for pelvic or vulvar cancer.I have not had surgery to remove lymph nodes.I have had surgery on the blood vessels in my legs.I have a history of heart failure, kidney, or liver disease.
- Group 1: Supportive care (lymphedema assessment)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In which locations is this experiment being administered?
"Currently, this trial is seeking to recruit 100 patients from various sites; some of these include the University of Iowa/Holden Comprehensive Cancer Center in Iowa City, Union Hospital of Cecil County in Elkton, and Sutter Cancer Research Consortium in Novato."
Are any additional participants still being accepted into this scientific experiment?
"The details hosted on clinicaltrials.gov suggest that this research project is not actively enrolling candidates at the present moment in time. It was first announced to the public on June 1st 2012 and last updated 3rd May 2017, while there are presently 419 other trials recruiting patients across a variety of healthcare specialties."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger